When choosing peptide bioregulators, we often come across two main categories – cytomaxes and cytogens. The cytomax production process involves special processing of organ tissues during which short peptides (2-4 amino acid chains) are isolated. Although both types work on a similar principle, they have fundamental differences that are important to understand before starting a course. In this article we explain those differences in detail and help you choose the most suitable option.
Contents
What are cytomaxes (natural peptides)?
Cytomaxes are natural peptide bioregulators, derived from organs and tissues of animal origin. They were developed by Professor Vladimir Khavinson's team and are the first generation of peptide bioregulators, with the longest history of clinical research.
The cytomax production process involves special processing of organ tissues during which short peptides (2-4 amino acid chains) are isolated. These peptides retain the full natural informational structure characteristic of the particular organ.
The most popular cytomaxes:
Advantages of cytomaxes:
- A complete peptide complex with the full natural information
- The longest history of clinical research (40+ years)
- A peptide complex of broader composition
- Often chosen for the main 30-day course
Synthetic peptides (cytogens) are created in the laboratory
Products covered in this article
€184,10 €204,60
€184,10 €204,60
€184,10 €204,60
What are cytogens (synthetic peptides)?
Cytogens are synthetic peptide bioregulators, created in the laboratory by reproducing the structure of natural peptides. They are a new-generation product, developed on the basis of the research into cytomaxes.
Each cytogen is a single specific peptide sequence that matches exactly the active fragment of the natural peptide. They are made by chemical synthesis and are therefore not of animal origin.
The most popular cytogens:
Advantages of cytogens:
- A precisely defined molecular structure
- Suitable for vegetarians and vegans (not of animal origin)
- Easier to standardise the production process
- Ideal for maintenance use between cytomax courses
Comparison table
| Property | Cytomaxes | Cytogens |
|---|---|---|
| Origin | Natural (animal tissues) | Synthetic (laboratory) |
| Composition | Peptide complex | Single peptide |
| Scope of composition | Broader (peptide complex) | Targeted (single peptide) |
| Suitable for vegetarians | No | Yes |
| Recommended use | Main courses | Maintenance courses |
When to choose cytomaxes?
Cytomaxes are the best choice when:
- You are starting your first peptide course and want a complex of full composition
- You want to support the function of a specific organ
- You want to complete a full 30-day course
- You are looking for a preparation of full composition for a specific organ
When to choose cytogens?
Cytogens are a better fit when:
- You have already completed a cytomax course and want to maintain the result
- You follow a vegetarian or vegan diet
- You want a targeted effect on a specific function
- You take peptides for everyday health maintenance
Optimal combination: cytomaxes + cytogens
Many users choose to combine both types. A popular schedule:
Cytomaxes and cytogens can also be taken at the same time for different organs. For example, Cerluten (a cytomax for the brain) together with Kristagen (a cytogen for immunity).
Whichever type you choose, peptide bioregulators are food supplements intended to help maintain the normal function of organs. Visit our store and explore the full range.
See the rangeClinical studies of peptide bioregulators
Sources
- 1. Khavinson, V.Kh. “Peptides and Ageing.” Neuroendocrinology Letters, Vol. 24, No. 3-4, 2003, pp. 144–149.
- 2. Khavinson, V.Kh., Malinin, V.V. Gerontological Aspects of Genome Peptide Regulation. Karger, Basel, 2005.
- 3. Khavinson, V. “Peptide regulation of aging: 35-year research experience.” Bulletin of Experimental Biology and Medicine, Vol. 152, No. 1, 2011, pp. 7–12.
- 4. Institute of Bioregulation and Gerontology – scientific publications and clinical trial data (Institute of Bioregulation and Gerontology).
- 5. Khavinson, V.Kh., et al. “Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.” Bulletin of Experimental Biology and Medicine, Vol. 135, No. 6, 2003, pp. 590–592.
